Source:http://linkedlifedata.com/resource/pubmed/id/12065109
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-6-14
|
pubmed:abstractText |
Endovascular brachytherapy (EVBT) has been proven to significantly reduce restenosis after percutaneous transluminal angioplasty (PTA). The object of this analysis was to assess the possible correlation between iridium-192 source non-centering and angiographic-determined restenosis. MATERIALS and
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0167-8140
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
97-102
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:12065109-Angioplasty, Balloon, Coronary,
pubmed-meshheading:12065109-Brachytherapy,
pubmed-meshheading:12065109-Femoral Artery,
pubmed-meshheading:12065109-Follow-Up Studies,
pubmed-meshheading:12065109-Graft Occlusion, Vascular,
pubmed-meshheading:12065109-Humans,
pubmed-meshheading:12065109-Iridium Radioisotopes,
pubmed-meshheading:12065109-Popliteal Artery,
pubmed-meshheading:12065109-Radiotherapy Dosage
|
pubmed:year |
2002
|
pubmed:articleTitle |
Possible impact of iridium-192 source centering on restenosis rate after femoro-popliteal angioplasty and endovascular brachytherapy in Vienna-2 study.
|
pubmed:affiliation |
Department of Radiotherapy, Vienna University Hospital, Währinger Gürtel 18-20, Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|